Advanced Solid Tumors clinical trials

Explore recruiting advanced solid tumors clinical trials.

Recruiting advanced solid tumors studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Solid Tumors trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase II, Open-Label, Multi-Drug, Multi-Center, Master Protocol to Evaluate the Efficacy and Safety of Novel Immunomodulators as Monotherapy and in Combination with Anticancer Agents in Participants with Advanced Hepatobiliary Cancer (GEMINI-Hepatobiliary)

Spain, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 1/2, Multicenter, Open Label, Dose Escalation & Dose Expansion Study of JK08, an IL-15 Antibody Fusion Protein Targeting CTLA-4, Monotherapy or in Combination in Patients with Unresectable Locally Advanced or Metastatic Cancer

Spain, Belgium

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Phase 1/2a Clinical Trial of BI-1206, a Monoclonal Antibody to CD32b (FcγRIIB), in Combination with Pembrolizumab in Subjects with Advanced Solid Tumors

Sweden, Poland, Romania, Germany, Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Phase 1b/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5764227 in combination with Standard of Care (SoC) or other agents in Participants with Advanced Solid Tumors

Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Phase I Study of INCB099280 in Combination With Ipilimumab in Participants With Selected Solid Tumors

Sweden, Norway, Slovakia

Human Pharmacology (Phase I)- Other EU CTIS Study details

A PHASE 2 STUDY EVALUATING INCB099280 IN PARTICIPANTS WITH SELECT SOLID TUMORS WHO ARE IMMUNE CHECKPOINT INHIBITOR–NAÏVE

Romania, Hungary, Greece

Therapeutic exploratory (Phase II) EU CTIS Study details

Advanced Solid Tumors trials by city

Advanced Solid Tumors in Toronto Advanced Solid Tumors in Vancouver Advanced Solid Tumors in Montreal Advanced Solid Tumors in Calgary Advanced Solid Tumors in Edmonton Advanced Solid Tumors in Ottawa Advanced Solid Tumors in Winnipeg Advanced Solid Tumors in Quebec City Advanced Solid Tumors in Hamilton Advanced Solid Tumors in Kitchener Advanced Solid Tumors in London Advanced Solid Tumors in Halifax Advanced Solid Tumors in New York Advanced Solid Tumors in Los Angeles Advanced Solid Tumors in Chicago Advanced Solid Tumors in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease